6 years ago

NuVision Biotherapies Raises £1.4m for Dry Eye Disease Therapy

  • NuVision Biotherapies, a UK-based regenerative medicine company, has secured £1.4m in funding

  • The funding will be used to fund clinical trials on its new treatment for dry eye disease.

      • ProblemHealthcare

      "improving treatments for dry eye disease and expanding into wound treatment"

      Solution

      "developing a regenerative medicine therapy using amniotic membrane and a contact lens product for outpatient application"

      Covered on